Shaw Christine
VP, Assay Development at GenMark Diagnostics, Inc.
- Sold, on record
- $86k
- Dollars the filings state
- Form 4 sales
- 9
- Latest Mar 5, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- GenMark Diagnostics, Inc.VP, Assay Development
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale GenMark Diagnostics, Inc.Plan not statedSep 8, 2020 2020
Sold 285 shares at $11.02 ($3k)
Shaw Christine, VP, Assay Development
Sold 0.4% of holdings ($882k position)79,714 shares leftFiling
- 2 Form 4 sale GenMark Diagnostics, Inc.Plan not statedOct 27, 2020 +49 days
Sold 68 shares at $11.34 ($771)
Shaw Christine, VP, Assay Development
Sold 0.1% of holdings ($904k position)79,646 shares leftFiling
- 3 Form 4 sale GenMark Diagnostics, Inc.Plan not statedNov 24, 2020 +28 days
Sold 355 shares at $13.17 ($5k)
Shaw Christine, VP, Assay Development
Sold 0.4% of holdings ($1M position)79,291 shares left1.2x usual sizeFiling
- 4 Form 4 sale GenMark Diagnostics, Inc.Plan not statedDec 7, 2020 +13 days
Sold 274 shares at $13.97 ($4k)
Shaw Christine, VP, Assay Development
Sold 0.3% of holdings ($1.1M position)79,877 shares left0.9x usual sizeFiling
- 5 Form 4 sale GenMark Diagnostics, Inc.Plan not statedJan 27, 2021 +51 days
Sold 81 shares at $14.06 ($1k)
Shaw Christine, VP, Assay Development
Sold 0.1% of holdings ($1.1M position)79,796 shares left0.3x usual sizeFiling
- 6 Form 4 sale GenMark Diagnostics, Inc.Plan not statedFeb 24, 2021 +28 days
Sold 425 shares at $19.21 ($8k)
Shaw Christine, VP, Assay Development
Sold 0.4% of holdings ($2M position)105,621 shares left1.5x usual sizeFiling
- 7 Form 4 sale GenMark Diagnostics, Inc.UnusualFeb 26, 2021 +2 days
Sold 3,151 shares at $17.03 ($54k)
Shaw Christine, VP, Assay Development
Sold 3% of holdings ($1.8M position)102,470 shares left11.1x usual sizeFiling
- 8 Form 4 sale GenMark Diagnostics, Inc.Plan not statedMar 5, 2021 +7 days
Sold 274 shares at $18.56 ($5k)
Shaw Christine, VP, Assay Development
Sold 0.3% of holdings ($1.9M position)102,196 shares left0.9x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (9)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2021 | Mar 8, 2021 | GenMark Diagnostics, Inc. | VP, Assay Development | Form 4 sale | 274 | $5k | 0.3% | Plan not stated | SEC |
| Feb 26, 2021 | Mar 1, 2021 | GenMark Diagnostics, Inc. | VP, Assay Development | Form 4 sale | 3,151 | $54k | 3.0% | Unusual | SEC |
| Feb 24, 2021 | Feb 25, 2021 | GenMark Diagnostics, Inc. | VP, Assay Development | Form 4 sale | 425 | $8k | 0.4% | Plan not stated | SEC |
| Jan 27, 2021 | Jan 29, 2021 | GenMark Diagnostics, Inc. | VP, Assay Development | Form 4 sale | 81 | $1k | 0.1% | Plan not stated | SEC |
| Dec 7, 2020 | Dec 9, 2020 | GenMark Diagnostics, Inc. | VP, Assay Development | Form 4 sale | 274 | $4k | 0.3% | Plan not stated | SEC |
| Nov 24, 2020 | Nov 25, 2020 | GenMark Diagnostics, Inc. | VP, Assay Development | Form 4 sale | 355 | $5k | 0.4% | Plan not stated | SEC |
| Oct 27, 2020 | Oct 29, 2020 | GenMark Diagnostics, Inc. | VP, Assay Development | Form 4 sale | 68 | $771 | 0.1% | Plan not stated | SEC |
| Sep 8, 2020 | Sep 10, 2020 | GenMark Diagnostics, Inc. | VP, Assay Development | Form 4 sale | 285 | $3k | 0.4% | Plan not stated | SEC |
| Aug 25, 2020 | Aug 26, 2020 | GenMark Diagnostics, Inc. | VP, Assay Development | Form 4 sale | 379 | $5k | 0.5% | Plan not stated | SEC |